<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Immunology Product Guide &#187; alemtuzumab</title>
	<atom:link href="http://www.immunologyproductguide.com/blog/tag/alemtuzumab/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.immunologyproductguide.com/blog</link>
	<description>A comprehensive guide to immunology products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 10:09:04 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Alemtuzumab can treat MS effectively</title>
		<link>http://www.immunologyproductguide.com/blog/2008/10/24/alemtuzumab-can-treat-ms-effectively/</link>
		<comments>http://www.immunologyproductguide.com/blog/2008/10/24/alemtuzumab-can-treat-ms-effectively/#comments</comments>
		<pubDate>Fri, 24 Oct 2008 05:56:14 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Antibodies]]></category>
		<category><![CDATA[Immune System Disorders]]></category>
		<category><![CDATA[alemtuzumab]]></category>
		<category><![CDATA[immune system disorder]]></category>
		<category><![CDATA[leukemia]]></category>
		<category><![CDATA[multiple sclerosis]]></category>
		<category><![CDATA[University of Cambridge]]></category>

		<guid isPermaLink="false">http://www.immunologyproductguide.com/blog/2008/10/24/alemtuzumab-can-treat-ms-effectively/</guid>
		<description><![CDATA[Scientists from the University of Cambridge have found that alemtuzumab, a drug originally developed for leukemia can curb the progression of multiple sclerosis (MS) even reverse some damage caused by the neurological disorder. The drug, a monoclonal antibody, has also been tested for treatment of other immune system disorders. Alemtuzumab targets the cells of the [...]]]></description>
			<content:encoded><![CDATA[<p><img src="http://www.immunologyproductguide.com/blog/wp-content/uploads/2008/10/alemtuzumab.png" align="left" height="74" hspace="5" vspace="5" width="200" />Scientists from the University of Cambridge have found that alemtuzumab, a drug originally developed for leukemia can curb the progression of multiple sclerosis (MS) even reverse some damage caused by the neurological disorder. The drug, a monoclonal antibody, has also been tested for treatment of other immune system disorders. Alemtuzumab targets the cells of the immune system that attack the myelin sheath and the nerve fibers.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.immunologyproductguide.com/blog/2008/10/24/alemtuzumab-can-treat-ms-effectively/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
